Register for streaming realtime charts, analysis tools, and prices.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Better Therapeutics Inc (BTTX)
Better Therapeutics Inc (BTTX) News

BTTX

Better Therapeutics (BTTX)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:BTTX

1 2 3 4 5 6 7 8 Next >>

Date	Time	Source	Headline	Symbol	Company
03/14/2024	9:38AM	Business Wire	Better Therapeutics Announces it will Seek Strategic Alternatives and will be Delisted from Nasdaq	NASDAQ:BTTX	Better Therapeutics Inc
03/11/2024	9:01AM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BTTX	Better Therapeutics Inc
03/05/2024	9:25AM	Business Wire	Better Therapeutics Announces an Innovative Partnership with the American College of Lifestyle Medicine to Expand Access to AspyreRx Across 1,400 Federally Qualified Health Centers	NASDAQ:BTTX	Better Therapeutics Inc
03/04/2024	9:25AM	Business Wire	Better Therapeutics Announces Acceptance of Late Breaking Abstract for Its AspyreRx Pivotal Trial 180 Day Outcomes and Participation at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)	NASDAQ:BTTX	Better Therapeutics Inc
03/04/2024	8:51AM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BTTX	Better Therapeutics Inc
03/01/2024	6:08AM	Edgar (US Regulatory)	Form RW - Registration Withdrawal Request	NASDAQ:BTTX	Better Therapeutics Inc
02/20/2024	9:25AM	Business Wire	Better Therapeutics Receives FDA Breakthrough Device Designation for Digital Therapeutic Platform Targeting Advanced Liver Disease	NASDAQ:BTTX	Better Therapeutics Inc
02/12/2024	4:28PM	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:BTTX	Better Therapeutics Inc
02/06/2024	9:43AM	Business Wire	Better Therapeutics Signs Rebate Agreement with One of the Largest Pharmacy Benefit Managers in the US for its AspyreRx Diabetes Treatment	NASDAQ:BTTX	Better Therapeutics Inc
02/06/2024	9:02AM	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:BTTX	Better Therapeutics Inc
01/25/2024	4:30PM	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:BTTX	Better Therapeutics Inc
01/23/2024	5:22PM	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:BTTX	Better Therapeutics Inc
01/17/2024	9:28AM	Business Wire	Better Therapeutics Announces Publication of Cost-Effectiveness Analysis Demonstrating AspyreRx is More Effective and Less Costly than Standard of Care Alone	NASDAQ:BTTX	Better Therapeutics Inc
01/10/2024	7:01AM	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:BTTX	Better Therapeutics Inc
01/08/2024	4:42PM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BTTX	Better Therapeutics Inc
01/04/2024	2:00PM	Business Wire	Better Therapeutics and Glooko Announce Partnership to Accelerate Adoption of AspyreRx to Treat Type 2 Diabetes in the United States	NASDAQ:BTTX	Better Therapeutics Inc
01/02/2024	7:45AM	Business Wire	Better Therapeutics Announces Submission for FDA Breakthrough Device Designation for Digital Therapeutic Platform to Treat Liver Disease	NASDAQ:BTTX	Better Therapeutics Inc
12/28/2023	9:23PM	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:BTTX	Better Therapeutics Inc
12/28/2023	12:15AM	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:BTTX	Better Therapeutics Inc
12/21/2023	5:21PM	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:BTTX	Better Therapeutics Inc
12/20/2023	5:23PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BTTX	Better Therapeutics Inc
12/20/2023	5:21PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BTTX	Better Therapeutics Inc
12/20/2023	5:10PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BTTX	Better Therapeutics Inc
12/13/2023	5:24PM	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:BTTX	Better Therapeutics Inc
12/13/2023	5:06PM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BTTX	Better Therapeutics Inc
12/07/2023	8:09PM	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:BTTX	Better Therapeutics Inc
11/30/2023	4:10PM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BTTX	Better Therapeutics Inc
11/28/2023	7:45AM	Business Wire	Better Therapeutics Strengthens Financial Position Through Amendment to Debt Facility and Implementation of Cost Reductions	NASDAQ:BTTX	Better Therapeutics Inc
11/20/2023	5:08PM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BTTX	Better Therapeutics Inc
11/14/2023	7:00AM	Business Wire	Frost & Sullivan Honors Better Therapeutics with the 2023 Technology Innovation Leadership Award	NASDAQ:BTTX	Better Therapeutics Inc

Showing the most relevant articles for your search:NASDAQ:BTTX

1 2 3 4 5 6 7 8 Next >>

Branded Legacy (PK)

Net Savings Link (PK)

Clean Vision (QB)

Therapeutic Solutions (PK)

FBEC Worldwide (PK)

Buildablock (PK)

Sunshine Biopharma

Ronn Motor (PK)

Enzolytics (PK)

Hannover House (PK)

BlackStar Enterprise (PK)

Bell Buckle (PK)

Delayed Upgrade Clock